Michael Bruckman

Mike Bruckman, CEO of Haima Therapeutics. With a PhD in organic chemistry and additional training in biomedical engineering and management, Mike joined the founding team at Haima as CEO in 2018 and has led their commercialization. Having brought in over $13mm in government funding to support their program over the last 5 years, Haima was the sole team selected by DARPA to receive funding in pursuit of manufacturing a fully-dried whole-blood product. Haima is a biopharma Cleveland-based company d...